Javascript must be enabled to continue!
Neuronal Activity-Induced BRG1 Phosphorylation Regulates Enhancer Activation
View through CrossRef
SUMMARY
Neuronal activity-induced enhancers drive the gene induction in response to stimulation. Here, we demonstrate that BRG1, the core subunit of SWI/SNF-like BAF ATP-dependent chromatin remodeling complexes, regulates neuronal activity-induced enhancers. Upon stimulation, BRG1 is recruited to enhancers in an H3K27Ac-dependent manner. BRG1 regulates enhancer basal activities and inducibility by affecting cohesin binding, enhancer-promoter looping, RNA polymerase II recruitment, and enhancer RNA expression. Furthermore, we identified a serine phosphorylation site in BRG1 that is induced by neuronal activities and is sensitive to CaMKII inhibition. BRG1 phosphorylation affects its interaction with several transcription co-factors, possibly modulating BRG1 mediated transcription outcomes. Using mice with knock-in mutations, we showed that non-phosphorylatable BRG1 fails to efficiently induce activity-dependent genes, whereas phosphomimic BRG1 increases the enhancer activities and inducibility. These mutant mice displayed anxiety-like phenotypes and altered responses to stress. Therefore, our data reveal a mechanism connecting neuronal signaling to enhancer activities through BRG1 phosphorylation.
Title: Neuronal Activity-Induced BRG1 Phosphorylation Regulates Enhancer Activation
Description:
SUMMARY
Neuronal activity-induced enhancers drive the gene induction in response to stimulation.
Here, we demonstrate that BRG1, the core subunit of SWI/SNF-like BAF ATP-dependent chromatin remodeling complexes, regulates neuronal activity-induced enhancers.
Upon stimulation, BRG1 is recruited to enhancers in an H3K27Ac-dependent manner.
BRG1 regulates enhancer basal activities and inducibility by affecting cohesin binding, enhancer-promoter looping, RNA polymerase II recruitment, and enhancer RNA expression.
Furthermore, we identified a serine phosphorylation site in BRG1 that is induced by neuronal activities and is sensitive to CaMKII inhibition.
BRG1 phosphorylation affects its interaction with several transcription co-factors, possibly modulating BRG1 mediated transcription outcomes.
Using mice with knock-in mutations, we showed that non-phosphorylatable BRG1 fails to efficiently induce activity-dependent genes, whereas phosphomimic BRG1 increases the enhancer activities and inducibility.
These mutant mice displayed anxiety-like phenotypes and altered responses to stress.
Therefore, our data reveal a mechanism connecting neuronal signaling to enhancer activities through BRG1 phosphorylation.
Related Results
Abstract 1651: Targeting intermediates of the PRMT5/BRG1 axis as a combination therapy
Abstract 1651: Targeting intermediates of the PRMT5/BRG1 axis as a combination therapy
Abstract
Over 40% of colorectal cancer (CRC) patients harbor a mutation in the KRAS gene, leading to a worse prognosis. PRMT5 and BRG1 are proteins considered potent...
Abstract 2995: CDK9 phosphorylates BRG1 chromatin remodeler
Abstract 2995: CDK9 phosphorylates BRG1 chromatin remodeler
Abstract
Cyclin-dependent kinase 9 (CDK9) belongs to the class of CDKs involved in transcription regulation along with CDK7, 8, 10-13. Earlier works have established...
Abstract 1769: A selective BRM (SMARCA2) inhibitor for the treatment of BRG1 (SMARCA4) mutant cancers
Abstract 1769: A selective BRM (SMARCA2) inhibitor for the treatment of BRG1 (SMARCA4) mutant cancers
Abstract
Background:
ATP-dependent BRG1/BRM associated factor complexes play a key role in regulating gene expression by remodel...
Regulation of ATM and ATR by Smarcal1 and BRG1
Regulation of ATM and ATR by Smarcal1 and BRG1
ABSTRACTThe G2/M checkpoint is activated on DNA damage by the ATM and ATR kinases that are regulated by post-translational modifications. In this paper, the transcriptional co-regu...
Abstract 602: Silencing BRG1 in human cancers
Abstract 602: Silencing BRG1 in human cancers
Abstract
BRG1 is a novel tumor suppressor that serves as the major catalytic subunit of the SWI/SNF complex. Because this complex is central to the function of a num...
A reversible KO model reveals therapeutic potentials of defective Tregs
A reversible KO model reveals therapeutic potentials of defective Tregs
ABSTRACT
Tregs must be activated to suppress immune responses, but the transcriptional program controlling Treg activation remains incompletely u...
The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation
The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation
ABSTRACT
Skeletal muscle differentiation induces changes in the epigenome of myoblasts as they proceed towards a myogenic phenotype. mSWI/SNF chromatin remodeling e...
Metabolically induced neuronal differentiation
Metabolically induced neuronal differentiation
In recent years, several neuronal differentiation protocols were published that circumvent the requirement of embryoid body (EB) formation under serum-deprivation and simplified me...

